Not applicableStudy completedNCT02769923What this trial is testingID Administration of fIPV Using Intradermal Adapters vs. BCG SyringeWho this might be right forIPV Aga Khan University 450
Testing effectiveness (Phase 2)Study completedNCT06754384What this trial is testingTolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).Who this might be right forHand, Foot, and Mouth Disease (HFMD)Herpangina Sinovac Biotech Co., Ltd 552
Early research (Phase 1)Study completedNCT05016687What this trial is testingFirst-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.Who this might be right forPulmonary Disease, Chronic ObstructiveEnterovirus InfectionsRhinovirus Curovir AB 74
Post-approval studies (Phase 4)Study completedNCT04133584What this trial is testingThe Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza VaccineWho this might be right forSeasonal InfluenzaHand, Foot and Mouth Disease Zhejiang Provincial Center for Disease Control and Prevention 1,134
Post-approval studies (Phase 4)Study completedNCT02853929What this trial is testingEvaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-deliveryWho this might be right forDiphtheriaHepatitis BAcellular Pertussis+4 more GlaxoSmithKline 551
Not applicableUnknownNCT03830073What this trial is testingAssessment of the Different Etiological and Susceptibility Markers in Patients With Pancreatitis: Investigating IG4, Cytomegalovirus, Coxsackie- Virus, Genetic Polymorphism of Vitamin D Receptor GeneWho this might be right forAcute Pancreatitis Assiut University 100
Large-scale testing (Phase 3)Study completedNCT01701401What this trial is testingSafety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCVWho this might be right forChronic Hepatitis C Virus Gilead Sciences 870
Post-approval studies (Phase 4)UnknownNCT02806531What this trial is testingSafety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months OldWho this might be right forEnterovirus 71 Vaccine Beijing Chaoyang District Centre for Disease Control and Prevention 20,000
Large-scale testing (Phase 3)Study completedNCT02458183What this trial is testingVaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruSWho this might be right forDiphtheriaTetanusPertussis+1 more Boryung Pharmaceutical Co., Ltd 476
Large-scale testing (Phase 3)Study completedNCT01453348What this trial is testingStudy to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate VaccineWho this might be right forMeningococcal DiseaseMeningococcal MeningitisHepatitis A+1 more Novartis Vaccines 252
Post-approval studies (Phase 4)Study completedNCT03873740What this trial is testingImmunogenicity and Safety of Two Different Commercial EV71 VaccinesWho this might be right forHand, Foot and Mouth Disease Sinovac Biotech Co., Ltd 300
Not applicableStudy completedNCT01105559What this trial is testingAntibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control VaccineWho this might be right forDiphtheriaTetanusWhooping Cough+2 more Sanofi 455
Large-scale testing (Phase 3)Study completedNCT01309646What this trial is testingImmunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib VaccineWho this might be right forPoliomyelitisTetanusAcellular Pertussis+2 more GlaxoSmithKline 454
Post-approval studies (Phase 4)UnknownNCT01908114What this trial is testingTo Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in PakistanWho this might be right forPolioPolio Sero ConversionPolio Sero Prevalence+1 more Aga Khan University 60,000
Testing effectiveness (Phase 2)Study completedNCT02347423What this trial is testing3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to InfantsWho this might be right forPoliomyelitis Statens Serum Institut 824
Large-scale testing (Phase 3)Study completedNCT05033561What this trial is testingStudy to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in InfantsWho this might be right forPoliomyelitis Fidec Corporation 905
Large-scale testing (Phase 3)Study completedNCT01177722What this trial is testingDTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American InfantsWho this might be right forDiphtheriaTetanusWhooping Cough+2 more Sanofi Pasteur, a Sanofi Company 1,375
Large-scale testing (Phase 3)Study completedNCT01353703What this trial is testingImmunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) VaccineWho this might be right forPoliomyelitisTetanusAcellular Pertussis+4 more GlaxoSmithKline 224
Post-approval studies (Phase 4)Study completedNCT01491087What this trial is testingSafety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaWho this might be right forDiphtheriaTetanusPertussis+1 more Sanofi Pasteur, a Sanofi Company 900
Post-approval studies (Phase 4)Study completedNCT03546634What this trial is testingSero-conversion Study for a Two-dose Schedule of Sabin IPV in ChinaWho this might be right forPoliomyelitis Centers for Disease Control and Prevention, China 280